Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Vitae Pharmaceuticals, Inc | a2221442zs-1a.htm |
| EX-5.1 - EX-5.1 - Vitae Pharmaceuticals, Inc | a2221442zex-5_1.htm |
| EX-10.8 - EX-10.8 - Vitae Pharmaceuticals, Inc | a2221442zex-10_8.htm |
| EX-10.6 - EX-10.6 - Vitae Pharmaceuticals, Inc | a2221442zex-10_6.htm |
| EX-10.10 - EX-10.10 - Vitae Pharmaceuticals, Inc | a2221442zex-10_10.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated June 27, 2014 (except for Note 15, as to which the date is September 8, 2014), in Amendment No. 5 to the Registration Statement (Form S-1 No. 333-198090) and related Prospectus of Vitae Pharmaceuticals, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP
Philadelphia,
Pennsylvania
September 22, 2014
Consent of Independent Registered Public Accounting Firm